The Board of Directors of Anhui Anke Biotechnology (Group) Co., Ltd. has authorized a buyback plan on February 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.83 CNY | +0.57% | -2.54% | -13.60% |
25/04 | Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
28/03 | Anhui Anke Biotechnology Co., Ltd. Proposes Final Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.60% | 2.03B | |
+2.22% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+76.30% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- 300009 Stock
- News Anhui Anke Biotechnology (Group) Co., Ltd.
- Anhui Anke Biotechnology Co., Ltd. authorizes a Buyback Plan.